rs786205448
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM1PM2PP2PP3PP5_Strong
The NM_170707.4(LMNA):c.1774G>A(p.Gly592Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000031 in 1,612,426 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_170707.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LMNA | NM_170707.4 | c.1774G>A | p.Gly592Arg | missense_variant | Exon 11 of 12 | ENST00000368300.9 | NP_733821.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152196Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460230Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 726430
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152196Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74362
ClinVar
Submissions by phenotype
not provided Pathogenic:2
- -
- -
Charcot-Marie-Tooth disease type 2 Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 592 of the LMNA protein (p.Gly592Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with poikiloderma, joint motion restriction and distal acroosteolysis (PMID: 26733286). ClinVar contains an entry for this variant (Variation ID: 190987). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt LMNA protein function with a positive predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Congenital muscular dystrophy due to LMNA mutation Uncertain:1
- -
Hutchinson-Gilford syndrome;C0410190:Emery-Dreifuss muscular dystrophy 2, autosomal dominant;C0796031:Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome;C1449563:Dilated cardiomyopathy 1A;C1720860:Familial partial lipodystrophy, Dunnigan type;C1854154:Charcot-Marie-Tooth disease type 2B1;C1857829:Heart-hand syndrome, Slovenian type;C2750035:Emery-Dreifuss muscular dystrophy 3, autosomal recessive;C2750785:Congenital muscular dystrophy due to LMNA mutation;C5399785:Mandibuloacral dysplasia with type A lipodystrophy;C5676942:Restrictive dermopathy 2 Uncertain:1
- -
Cardiovascular phenotype Uncertain:1
The p.G592R variant (also known as c.1774G>A), located in coding exon 11 of the LMNA gene, results from a G to A substitution at nucleotide position 1774. The glycine at codon 592 is replaced by arginine, an amino acid with dissimilar properties. This variant was reported in a homozygous male who had skin pigmentation changes and stiffened joints, and whose parents were first cousins; no other family members were reported to be affected (Sewairi W et al. Eur. J. Hum. Genet., 2016 08;24:1220-2; Maddirevula S et al. Genet. Med., 2018 12;20:1609-1616). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at